Green Light For U.S. Biosimilar Drug
Thursday, July 23, 2015 - 19:50
in Earth & Climate
Biologics: Biogen’s Zarxio prevails for now in court battle with Amgen, developer of Neupogen
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via